Abzena
Abzena is a contract development and manufacturing organization (CDMO) and contract research organization (CRO) specializing in complex biologics and bioconjugates. The company provides integrated services including antibody discovery, engineering, mammalian cell line development, and cGMP manufacturing for modalities such as antibody-drug conjugates (ADCs) and fusion proteins. They support biopharmaceutical partners from early-stage research and development through to clinical and commercial production.
Funding summary
- Total raised
- €27.8M
- Funding rounds
- 1
Investors in Abzena
Investors on record for Abzena. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Abzena?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors